Harbor Review
Best for: adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee
Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market. Plans include weekly medication, ongoing provider consultations, refill management, and free 48-hour discreet shipping. Physicians provide 24/7 access and dosage adjustments via secure patient portal. Post-program dietitian support included. LegitScript certified; 4.7-star rating with 10,000+ verified members; 12-month money-back guarantee. HSA/FSA eligible.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Harbor is one of the most affordable GLP-1 options on the market.
Harbor at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $99/mo (Weekly compounded semaglutide injection. Verbatim: 'From $99/mo'. Bundled plan covers medication, provider consultations, refill management, and shipping.)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Harbor
Each dimension is scored algorithmically from Harbor’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
9.3/10At $99/mo, Harbor runs about 41% below the $169 median for GLP-1 providers.
Effectiveness25%
8.3/10Harbor offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.0/10Online intake and platform experience — ongoing clinician messaging, consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.5/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-07-06).
Accessibility10%
6.7/10Harbor's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.6/10Clinician messaging between visits.
How we verified this Harbor review
Last checked 2026-07-06- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Harbor offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Weekly compounded semaglutide injection. Verbatim: 'From $99/mo'. Bundled plan covers medication, provider consultations, refill management, and shipping.
Weekly compounded tirzepatide injection. Verbatim: 'From $149/mo'. Bundled plan covers medication, provider consultations, refill management, and shipping.
Ready to get started?
Plans and promotions change often — check Harbor's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
- LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
- 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
- 12-Month Money Back Guarantee if you don't reach your weight-loss goal
- HSA/FSA eligible; no hidden fees, no insurance billed
Watch-outs
- Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
- Dietitian support offered only post-program (maintenance phase), not during active treatment
- State-specific consultation types vary; nationwide availability unconfirmed for all states
- No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
- Newer brand; success rate and member counts are on-site claims, not third-party verified
Is Harbor worth it? Our verdict
Harbor positions itself around one thing: adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee. It runs $99/month — toward the affordable end of the market.
Harbor rounds out its offering with LegitScript certified, 24/7 physician access, and Money-back guarantee.
How much Harbor actually costs
- Compounded semaglutide — $99/month
- Compounded tirzepatide — $149/month
That puts Harbor below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
For a direct comparison, Telos Rx runs semaglutide and tirzepatide from $49/month — worth pricing against Harbor before you commit.
Medications: what Harbor prescribes
Harbor prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Harbor is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- value being able to message a clinician between visits.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Harbor offers clinician messaging between visits. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Harbor earns its place on the shortlist mainly on price: at $99/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
Ready to start with Harbor?
Starting at $99/month. See current pricing and start your free consultation.
Harbor might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to Harbor
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Harbor review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Harbor?
Starting at $99/month. See current pricing and start your free consultation.